Cancer Research
106 articles · 3 journals
Journals in this subcategory (3)
- Cancer Genetics · Elsevier (58)
- Neoplasia · Elsevier (38)
- Oncogene · Springer Nature (10)
-
SIRT6 coordinates copper homeostasis to modulate cuproplasia and cuproptosis in colorectal cancer
Oncogene, Published online: 20 November 2026; doi:10.1038/s41388-026-04047-6 Colorectal cancer tissues contain high levels of copper. Copper can both promote tumor growth and trigger cell death. This study identifies a protein called...
-
Dysregulated ASH1L-MUC1-CD133 axis promotes lung metastasis and reprograms the metastatic niche in SPOP-deficient prostate cancer
Oncogene, Published online: 20 November 2026; doi:10.1038/s41388-026-04028-9 The spread of prostate cancer to other organs, known as metastasis, is the main cause of death from this disease. This study aimed to understand how changes in...
-
Extrachromosomal circular DNA in human cancer: from biogenesis mechanisms to therapeutic vulnerabilities
Oncogene, Published online: 19 November 2026; doi:10.1038/s41388-026-04055-6 Extrachromosomal circular DNA in human cancer: from biogenesis mechanisms to therapeutic vulnerabilities
-
PIM kinase inhibition induces epigenetically conditioned transcriptional changes, abnormal RNA splicing and DNA damage in diffuse large B-cell lymphoma cells
Oncogene, Published online: 18 November 2026; doi:10.1038/s41388-026-04044-9 PIM kinase inhibition induces epigenetically conditioned transcriptional changes, abnormal RNA splicing and DNA damage in diffuse large B-cell lymphoma cells
-
PDGF-BB and bFGF repress Kai1 in pericytes through Src–DNMT-associated promoter methylation and lysosomal trafficking
Oncogene, Published online: 14 November 2026; doi:10.1038/s41388-026-04014-1 PDGF-BB and bFGF repress Kai1 in pericytes through Src–DNMT-associated promoter methylation and lysosomal trafficking
-
Editorial Expression of Concern: Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey
Oncogene, Published online: 13 November 2026; doi:10.1038/s41388-026-04058-3 Editorial Expression of Concern: Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey
-
B3GNT9-mediated O-glycosylation reprograms fatty acid metabolism in peroxisomes to promote invasion progression of peritumoral glioma cells
Oncogene, Published online: 10 November 2026; doi:10.1038/s41388-026-03994-4 B3GNT9-mediated O-glycosylation reprograms fatty acid metabolism in peroxisomes to promote invasion progression of peritumoral glioma cells
-
Editorial Expression of Concern: Identification of novel VHL targets that are associated with the development of renal cell carcinoma
Oncogene, Published online: 09 November 2026; doi:10.1038/s41388-026-04045-8 Editorial Expression of Concern: Identification of novel VHL targets that are associated with the development of renal cell carcinoma
-
RHBDL2 promotes cancer stemness and chemoresistance in triple-negative breast cancer through EGFR/PI3K/AKT/mTOR/c-Myc pathway
Oncogene, Published online: 05 November 2026; doi:10.1038/s41388-026-04007-0 RHBDL2 promotes cancer stemness and chemoresistance in triple-negative breast cancer through EGFR/PI3K/AKT/mTOR/c-Myc pathway
-
Therapy-induced tumour senescence drives oxaliplatin resistance via ADORA1–dependent palmitic acid metabolic reprogramming in colorectal cancer
Oncogene, Published online: 03 November 2026; doi:10.1038/s41388-026-04024-z Early resistance to oxaliplatin-based neoadjuvant chemotherapy (NACT) remains a major obstacle to improving outcomes for patients with locally advanced...
- Combined dopamine receptor inhibition and radiotherapy target mesothelioma-initiating cells and increase survival in a mouse model of mesothelioma
- Integrated tissue and longitudinal ctDNA profiling reveal distinct genomic evolutionary trajectories associated with response to first-line immunotherapy and chemioimmunotherapy in advanced NSCLC patients
- m6A-Regulated Resistance to Immune Checkpoint Blockade in Cancer: Metabolic and RNA-Mediated Niches in the Tumor Microenvironment
- Therapy-Driven Evolution Across Tumor and Host: Linking Resistance, Clonal Hematopoiesis, and Long-Term Treatment Consequences
- ADAMTS9-AS1 and ADRA1D Are Associated with Urea Cycle Activity and Ammonia Stress Responses in Prostate Cancer
- Multi-Scale Invasion-Associated Proliferative Profiling with Spatial Validation Enables Non-Invasive CT-Based Prognosis in Lung Adenocarcinoma
- Transformation of Human Bronchial Epithelial Cells by Estrogen Metabolites: Implications for Lung Cancer in Never-Smokers
- Integrated multi-omics and experimental analyses characterize an IGF2BP3–MMP7-associated pattern in extracellular matrix remodeling and Treg-associated immune suppression in pancreatic adenocarcinoma
- Bidirectional interactions between radiotherapy and antibody-drug conjugates: targetability, toxicity and sequencing
- Characterization of the genomic landscape in liver-only metastatic colorectal cancer
- Enhancing TCR-T cell responses with a TGFβ-specific chimeric antigen receptor
- Single-cell analysis of epithelial transcriptional states identifies stromal associations and candidate targets in colon cancer
- Survival outcomes, prognostic factors, and molecular landscape of early-onset versus late-onset colorectal cancer: a SEER-based study with external validation and transcriptomic profiling
- Obstructive Sleep Apnea and Lung Cancer Risk: A Systematic Review with Meta-Analysis
- The FOXA1-MAOA axis drives prostate cancer progression and comorbid depression via a tumor-immunity-enteric neural network
- An EFHD1-associated ADSC niche modulates treatment response in experimental models of ER-positive breast cancer
- A Dendritic Cell-Related Prognostic Signature in Glioma: A Multi-Omic Framework Integrating Transcriptomics, Single-Cell Profiling, and Clinical Validation
- State- and niche-dependent cancer-associated fibroblasts in gastric cancer: epithelial plasticity and therapeutic implications
- Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers
- Ubiquitin-specific proteases and the immune microenvironment in cervical cancer: mechanistic evidence, immunotherapy resistance, and therapeutic perspectives